These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16806098

  • 21. Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population.
    Aoyama N, Takahashi N, Saito S, Maeno N, Ishihara R, Ji X, Miura H, Ikeda M, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Yoshida K, Iwata N, Inada T, Ozaki N.
    Genes Brain Behav; 2006 Jun; 5(4):364-8. PubMed ID: 16716206
    [Abstract] [Full Text] [Related]

  • 22. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Serretti A, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Pae CU.
    Psychiatry Res; 2011 Aug 30; 189(1):26-32. PubMed ID: 21396719
    [Abstract] [Full Text] [Related]

  • 23. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD.
    Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z.
    Mol Psychiatry; 2005 Oct 30; 10(10):944-9. PubMed ID: 15940290
    [Abstract] [Full Text] [Related]

  • 24. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
    Pae CU, Yu HS, Amann D, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH, Patkar AA, Lerer B.
    J Psychiatr Res; 2008 Jan 30; 42(1):35-40. PubMed ID: 17097106
    [Abstract] [Full Text] [Related]

  • 25. The interaction between TPH2 promoter haplotypes and clinical-demographic risk factors in suicide victims with major psychoses.
    De Luca V, Hlousek D, Likhodi O, Van Tol HH, Kennedy JL, Wong AH.
    Genes Brain Behav; 2006 Feb 30; 5(1):107-10. PubMed ID: 16436194
    [Abstract] [Full Text] [Related]

  • 26. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S, Caimi L, Padovani A.
    Neurobiol Aging; 2007 Aug 30; 28(8):1231-8. PubMed ID: 16837108
    [Abstract] [Full Text] [Related]

  • 27. Linkage of schizophrenia with TPH2 and 5-HTR2A gene polymorphisms in the Malay population.
    Tee SF, Chow TJ, Tang PY, Loh HC.
    Genet Mol Res; 2010 Jul 06; 9(3):1274-8. PubMed ID: 20623453
    [Abstract] [Full Text] [Related]

  • 28. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C.
    Neurology; 2007 Oct 30; 69(18):1745-50. PubMed ID: 17872362
    [Abstract] [Full Text] [Related]

  • 29. Positive association between synapsin II and schizophrenia.
    Chen Q, He G, Wang XY, Chen QY, Liu XM, Gu ZZ, Liu J, Li KQ, Wang SJ, Zhu SM, Feng GY, He L.
    Biol Psychiatry; 2004 Aug 01; 56(3):177-81. PubMed ID: 15271586
    [Abstract] [Full Text] [Related]

  • 30. Novel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia.
    Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H.
    J Hum Genet; 2000 Aug 01; 45(1):24-30. PubMed ID: 10697959
    [Abstract] [Full Text] [Related]

  • 31. Variability of the tryptophan hydroxylase gene: study in victims of violent suicide.
    Stefulj J, Kubat M, Balija M, Skavic J, Jernej B.
    Psychiatry Res; 2005 Mar 30; 134(1):67-73. PubMed ID: 15808291
    [Abstract] [Full Text] [Related]

  • 32. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
    Pae CU, Drago A, Kim JJ, Patkar AA, Jun TY, Lee C, Mandelli L, De Ronchi D, Paik IH, Serretti A.
    Neurosci Lett; 2008 Aug 01; 440(2):150-4. PubMed ID: 18562100
    [Abstract] [Full Text] [Related]

  • 33. A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia.
    Aoki-Suzuki M, Yamada K, Meerabux J, Iwayama-Shigeno Y, Ohba H, Iwamoto K, Takao H, Toyota T, Suto Y, Nakatani N, Dean B, Nishimura S, Seki K, Kato T, Itohara S, Nishikawa T, Yoshikawa T.
    Biol Psychiatry; 2005 Feb 15; 57(4):382-93. PubMed ID: 15705354
    [Abstract] [Full Text] [Related]

  • 34. Investigation of variants in the promoter region of PIK3C3 in schizophrenia.
    Tang R, Zhao X, Fang C, Tang W, Huang K, Wang L, Li H, Feng G, Zhu S, Liu H, He L, Shi Y.
    Neurosci Lett; 2008 May 23; 437(1):42-4. PubMed ID: 18420347
    [Abstract] [Full Text] [Related]

  • 35. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH, Lønning PE, Børresen-Dale AL, Kristensen VN.
    Pharmacogenet Genomics; 2007 Feb 23; 17(2):127-36. PubMed ID: 17301692
    [Abstract] [Full Text] [Related]

  • 36. Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia.
    Arai S, Shibata H, Sakai M, Ninomiya H, Iwata N, Ozaki N, Fukumaki Y.
    Psychiatr Genet; 2009 Feb 23; 19(1):6-13. PubMed ID: 19125103
    [Abstract] [Full Text] [Related]

  • 37. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder.
    Maron E, Tõru I, Must A, Tasa G, Toover E, Vasar V, Lang A, Shlik J.
    Neurosci Lett; 2007 Jan 16; 411(3):180-4. PubMed ID: 17123728
    [Abstract] [Full Text] [Related]

  • 38. Polymorphisms in glycine transporter with schizophrenia.
    Tsai SJ, Cheng CY, Hong CJ, Liao DL, Liou YJ.
    Neuropsychopharmacol Hung; 2006 Mar 16; 8(1):17-21. PubMed ID: 16841561
    [Abstract] [Full Text] [Related]

  • 39. Support for tryptophan hydroxylase-2 as a susceptibility gene for bipolar affective disorder.
    Roche S, McKeon P.
    Psychiatr Genet; 2009 Jun 16; 19(3):142-6. PubMed ID: 19352219
    [Abstract] [Full Text] [Related]

  • 40. Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia.
    Sáiz PA, García-Portilla MP, Arango C, Morales B, Alvarez V, Coto E, Fernández JM, Bascarán MT, Bousoño M, Bobes J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):741-5. PubMed ID: 17291660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.